In this edition...
- Hours to minutes Editorial team, Synaptic Software Limited
- Synaptic Pathways: the advice research revolution has arrived Eric Armstrong, Client Director, Synaptic Software Limited
- Value for money matters when assessing suitability John Warby, Senior Business Relationship Manager, Synaptic Software Limited
- The road ahead on suitability and disclosure Natalie Holt, Content Editor The Lang Cat
- Developing your investment proposition David A Norman (DAN), CEO TCF Investment
- State of the Nation Ian McKenna, Founder of Financial Technology Research Centre and AdviserSoftware.com FTRC
- Few places to hide Guy Monson, CIO and Senior Partner Sarasin & Partners
- Ensuring the “new normal” is a better normal Ben Lester, Head of Distribution – UK & International Praemium
- Stay the course if you can (but better too early than too late) James Klempster, Deputy Head of the Liontrust Multi-Asset team Liontrust
- Can financial goals be achieved through one fund? Mohneet Dhir, Multi-Asset Product Specialist Vanguard Europe
- Talking Trash: Why it’s not a waste of time Luke Barrs, Head of Fundamental Equity Client Portfolio Management for EMEA & Asia ex-Japan Goldman Sachs Asset Management
- Demand for growth funds rises amid risk-on environment Antony Champion, Head of Intermediaries Brewin Dolphin
- The best of both worlds Ian Jensen-Humphreys, Portfolio Manager Quilter Investors
- Global Sustainable Equity: a renewable, electric and digital future Hamish Chamberlayne, Head of Global Sustainable Equities | Portfolio Manager Janus Henderson
- Four steps to choose an ESG manager Daniel Ryan, Manager Research Analyst Fidelity International
- The path to retirement is changing … are you? Editorial team, Synaptic Software Limited
- Are unregulated investments ever a good idea? Jon Lycett, Business Development Manager RSMR
- Putting the children first Jacqui Gillies, Marketing and Proposition Director Guardian
- Why not Serious Illness Cover? Nick Telfer, Protection Development Manager VitalityLife
Most parents do everything in their power to protect their children. So why is children's critical illness cover so rarely discussed? It's the afterthought. And that's largely because of proposition design.
Considering its unique coverage, shouldn't advisers feel compelled to justify why they haven't recommended Serious Illness Cover, rather than why they have?
If we start from the customer perspective, it's hard for an adviser to justify not considering Serious Illness Cover as part of a critical illness recommendation to clients. Both have been designed to meet the same customer need: to protect against the financial and emotional impact of a major illness. Yes, they work slightly differently but the key difference is how and when they pay out.
"So rather than considering Serious Illness Cover to be different to Critical Illness Cover we need to see them as being part of a spectrum of solutions for advisers looking to satisfy this customer need."
The main reason for taking out any type of insurance is that it is there for you when you need it. Obviously, affordability also needs to be a consideration. From a protection advisers' perspective, the aim is therefore to strike a balance between the breadth of cover and a price which meets the client's budget.
As part of this, the likelihood of the plan paying out when the adviser and their client expects it to is key. Recommending a product with a higher propensity to pay out better not only protects the customer and minimises the potential for a poor outcome for the client. It also reduces the likelihood of an adviser needing to have the worst possible conversation with a client – to tell them they aren't covered when the thought they were.
More chance of a claim
The key advantage of Serious Illness Cover over critical illness cover is that there is a far higher likelihood of the planholder suffering a claimable condition1. It should therefore be considered when looking to protect a customer against the risk of serious or critical illness in our view. After all it reduces the risk of that worst possible conversation and an ensuing complaint.
This greater likelihood is because it covers significantly more conditions than any other provider2. In fact, our Serious Illness Cover includes 38 unique conditions and Serious Illness Cover Plus includes 613. But let's not get hung up on these numbers. To show how important that might be, in 2019 over 1 in 12 of our claims were for conditions that are unique to Vitality4. Three of the most common unique conditions claimed for were:
- Pulmonary Embolisms: a blocked blood vessel in the lung – around 28,000 people were hospitalised in 20115.
- Inflammatory Bowel Disease (without the need for surgery): the name for conditions such as Ulcerative Colitis and Crohns Disease – affects around 300,000 people in the UK6.
- Surgery for Cardiac Arrythmia: abnormal heart rhythm – affects around two million people per year in the UK7.
To put these into context Motor Neurone Disease, a dreadful condition is thought to affect around 5,000 people in the UK8.
As the above shows these are common conditions that have a real financial and emotional impact on people, and it wouldn't be unreasonable for a typical client diagnosed with one of these to consider them serious or critical illnesses. If that's the case they would be calling you, their adviser, expecting a payout but they would only get one if you had recommended Vitality Serious Illness Cover.
So next time you are speaking to a client about serious or critical illness think Vitality Serious Illness Cover – it better protects your customer and better protects your advice.
To discover how Serious Illness Cover could benefit your client, visit adviser.vitality.co.uk/sic
Sources:
- Defaqto verified Competitor Comparisons, Apr 2021.
- Defaqto verified Competitor Comparisons, Apr 2021
- Vitality Illness Comparison Tool, independently verified by Defaqto, April 2021
- Vitality Claims and Benefits Report, Jun 2020
- https://statistics.blf.org.uk/pulmonary-embolism
- https://www.calprotectin.co.uk/about-calprotectin/inflammatory-bowel-disease-ibd
- https://www.nhs.uk/conditions/arrhythmia/
- https://www.nice.org.uk/guidance/qs126/documents/briefing-paper
Sign up for updates
Keep up to speed with everything you need to know each quarter, by email or post.